BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8142619)

  • 21. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia.
    Mikhail FM; Coignet L; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Farahat N; Nucifora G
    Genes Chromosomes Cancer; 2004 Feb; 39(2):110-8. PubMed ID: 14695990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of DNA sequence in the binding specificity of synthetic basic-helix-loop-helix domains.
    Beltran AC; Dawson PE; Gottesfeld JM
    Chembiochem; 2005 Jan; 6(1):104-13. PubMed ID: 15593070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCL and related hemopoietic helix-loop-helix transcription factors.
    Green AR; Begley CG
    Int J Cell Cloning; 1992 Sep; 10(5):269-76. PubMed ID: 1453013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
    Hsu HL; Wadman I; Tsan JT; Baer R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
    Meyers S; Lenny N; Sun W; Hiebert SW
    Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcription factors of the bHLH and LIM families: synergistic mediators of T cell acute leukemia?
    Baer R; Hwang LY; Bash RO
    Curr Top Microbiol Immunol; 1997; 220():55-65. PubMed ID: 9103675
    [No Abstract]   [Full Text] [Related]  

  • 27. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.
    Robb L; Rasko JE; Bath ML; Strasser A; Begley CG
    Oncogene; 1995 Jan; 10(1):205-9. PubMed ID: 7824274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen.
    Hwang LY; Siegelman M; Davis L; Oppenheimer-Marks N; Baer R
    Oncogene; 1993 Nov; 8(11):3043-6. PubMed ID: 8414504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single split-signal FISH probe set allows detection of TAL1 translocations as well as SIL-TAL1 fusion genes in a single test.
    van der Burg M; Smit B; Brinkhof B; Barendregt BH; Verschuren MC; Dib M; Beverloo HB; van Dongen JJ; Langerak AW
    Leukemia; 2002 Apr; 16(4):755-61. PubMed ID: 11960364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromatin immunoselection defines a TAL-1 target gene.
    Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
    EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.
    Bash RO; Hall S; Timmons CF; Crist WM; Amylon M; Smith RG; Baer R
    Blood; 1995 Jul; 86(2):666-76. PubMed ID: 7605997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The T cell oncogene Tal2 is necessary for normal development of the mouse brain.
    Bucher K; Sofroniew MV; Pannell R; Impey H; Smith AJ; Torres EM; Dunnett SB; Jin Y; Baer R; Rabbitts TH
    Dev Biol; 2000 Nov; 227(2):533-44. PubMed ID: 11071772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21).
    Sjögren H; Wedell B; Meis-Kindblom JM; Kindblom LG; Stenman G
    Cancer Res; 2000 Dec; 60(24):6832-5. PubMed ID: 11156374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia.
    Janssen JW; Ludwig WD; Sterry W; Bartram CR
    Leukemia; 1993 Aug; 7(8):1204-10. PubMed ID: 8350619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lyl1 interacts with CREB1 and alters expression of CREB1 target genes.
    San-Marina S; Han Y; Suarez Saiz F; Trus MR; Minden MD
    Biochim Biophys Acta; 2008 Mar; 1783(3):503-17. PubMed ID: 18160048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.
    Hsu HL; Wadman I; Baer R
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3181-5. PubMed ID: 8159721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products.
    Prasad KS; Jordan JE; Koury MJ; Bondurant MC; Brandt SJ
    J Biol Chem; 1995 May; 270(19):11603-11. PubMed ID: 7744799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism.
    Goldfarb AN; Lewandowska K
    Blood; 1995 Jan; 85(2):465-71. PubMed ID: 7812000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concise review: Blood relatives: formation and regulation of hematopoietic stem cells by the basic helix-loop-helix transcription factors stem cell leukemia and lymphoblastic leukemia-derived sequence 1.
    Curtis DJ; Salmon JM; Pimanda JE
    Stem Cells; 2012 Jun; 30(6):1053-8. PubMed ID: 22593015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reconstitution of mice with bone marrow cells expressing the SCL gene is insufficient to cause leukemia.
    Elwood NJ; Begley CG
    Cell Growth Differ; 1995 Jan; 6(1):19-25. PubMed ID: 7718483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.